Sussex Blood Cancer Research
@sussexbcr.bsky.social
A network of research groups across the University of Sussex, Brighton & Sussex Medical School and University Hospitals Sussex NHS trust investigating the causes of blood cancers, and developing new therapeutic strategies to improve patient survival.
Pinned
We are now on Bluesky with our new name!
We are a network of research groups across the University of Sussex, Brighton & Sussex Medical School and University Hospitals Sussex NHS trust investigating the causes of blood cancers, and developing new therapeutic strategies to improve patient survival.
We are a network of research groups across the University of Sussex, Brighton & Sussex Medical School and University Hospitals Sussex NHS trust investigating the causes of blood cancers, and developing new therapeutic strategies to improve patient survival.
🗞️Publication update!🗞️
Congrats @chrispepper68.bsky.social @bsmsmedschool.bsky.social for his new paper in @pubs.acs.org Jnl of MedChem with @mirazrahman.bsky.social at @kingscollegelondon.bsky.social on generating new efflux-resistant TKIs for CML treatment. 👊
pubs.acs.org/doi/10.1021/...
Congrats @chrispepper68.bsky.social @bsmsmedschool.bsky.social for his new paper in @pubs.acs.org Jnl of MedChem with @mirazrahman.bsky.social at @kingscollegelondon.bsky.social on generating new efflux-resistant TKIs for CML treatment. 👊
pubs.acs.org/doi/10.1021/...
Design, Synthesis, and Biological Evaluation of Efflux-Resistant Imatinib Derivatives
Resistance to imatinib, a first-line BCR-ABL1 tyrosine kinase inhibitor for chronic myeloid leukemia, is frequently mediated by drug efflux through P-glycoprotein (P-gp) overexpression. We report the ...
pubs.acs.org
November 26, 2025 at 8:32 PM
🗞️Publication update!🗞️
Congrats @chrispepper68.bsky.social @bsmsmedschool.bsky.social for his new paper in @pubs.acs.org Jnl of MedChem with @mirazrahman.bsky.social at @kingscollegelondon.bsky.social on generating new efflux-resistant TKIs for CML treatment. 👊
pubs.acs.org/doi/10.1021/...
Congrats @chrispepper68.bsky.social @bsmsmedschool.bsky.social for his new paper in @pubs.acs.org Jnl of MedChem with @mirazrahman.bsky.social at @kingscollegelondon.bsky.social on generating new efflux-resistant TKIs for CML treatment. 👊
pubs.acs.org/doi/10.1021/...
Reposted by Sussex Blood Cancer Research
Well done to Drs Hyun Park and Aaron Goff from @biochembiomeduos.bsky.social @bsmsmedschool.bsky.social @sussexbcr.bsky.social who’ve both had abstracts accepted for presentation at the @ash.hematology.org 2025 meeting in December, and been awarded ASH achievement awards!
See you in Orlando! 🇺🇸
See you in Orlando! 🇺🇸
November 7, 2025 at 4:29 PM
Well done to Drs Hyun Park and Aaron Goff from @biochembiomeduos.bsky.social @bsmsmedschool.bsky.social @sussexbcr.bsky.social who’ve both had abstracts accepted for presentation at the @ash.hematology.org 2025 meeting in December, and been awarded ASH achievement awards!
See you in Orlando! 🇺🇸
See you in Orlando! 🇺🇸
Reposted by Sussex Blood Cancer Research
Tonight was the U.K. premier of ‘Goodbye Breasts’ written, directed and produced by Joanne Callaghan, documenting her remarkable breast cancer story. A must see!
@gdsc-sussex.bsky.social
@sussexcancer.org
@sussexbcr.bsky.social
sussexcancerfund.co.uk
@gdsc-sussex.bsky.social
@sussexcancer.org
@sussexbcr.bsky.social
sussexcancerfund.co.uk
November 11, 2025 at 10:33 PM
Tonight was the U.K. premier of ‘Goodbye Breasts’ written, directed and produced by Joanne Callaghan, documenting her remarkable breast cancer story. A must see!
@gdsc-sussex.bsky.social
@sussexcancer.org
@sussexbcr.bsky.social
sussexcancerfund.co.uk
@gdsc-sussex.bsky.social
@sussexcancer.org
@sussexbcr.bsky.social
sussexcancerfund.co.uk
Reposted by Sussex Blood Cancer Research
Looking for a PhD on stem cells, microenvironment and gene regulation/alternative splicing. Join us for this great project with @whatchamacaulay.bsky.social
PHD: Are you interested in gene regulation, #immune function, or tech development?
We have a fully-funded 4-year #PhDproject with @whatchamacaulay.bsky.social at the Earlham Institute and @tiagocluis.bsky.social at Imperial looking at niche cell–cell communication.
➡️ buff.ly/M7u6thJ
We have a fully-funded 4-year #PhDproject with @whatchamacaulay.bsky.social at the Earlham Institute and @tiagocluis.bsky.social at Imperial looking at niche cell–cell communication.
➡️ buff.ly/M7u6thJ
Exploring niche cell–cell communication through alternative splicing
4-year Norwich Research Park Biosciences Doctoral Training Partnership (NRPDTP) PhD
buff.ly
October 21, 2025 at 3:29 PM
Looking for a PhD on stem cells, microenvironment and gene regulation/alternative splicing. Join us for this great project with @whatchamacaulay.bsky.social
Reposted by Sussex Blood Cancer Research
Prof. Tim Humphrey and Dr. Rhys Morgan both gave talks at the recent "Science Café" hosted by the Sussex Cancer Fund in partnership with the Macmillan Horizon Centre. A fabulous series of short talks for anyone interested in hearing a little more about the latest developments in cancer research.
Delighted to wave the flag for @gdsc-sussex.bsky.social
@sussexcancer.org
@sussexbcr.bsky.social
sussexcancerfund.co.uk together with Rhys Morgan at the Science Cafe, MacMillan Horizon centre today. Thanks to Rebecca Herbertson and Stephen Robinson for organizing.
@rhysmorganlab.bsky.social
@sussexcancer.org
@sussexbcr.bsky.social
sussexcancerfund.co.uk together with Rhys Morgan at the Science Cafe, MacMillan Horizon centre today. Thanks to Rebecca Herbertson and Stephen Robinson for organizing.
@rhysmorganlab.bsky.social
September 30, 2025 at 2:41 PM
Prof. Tim Humphrey and Dr. Rhys Morgan both gave talks at the recent "Science Café" hosted by the Sussex Cancer Fund in partnership with the Macmillan Horizon Centre. A fabulous series of short talks for anyone interested in hearing a little more about the latest developments in cancer research.
🍾New promotion in the network! 🎉
A massive congratulations to Simon Mitchell @mitchell.science from @bsmsmedschool.bsky.social recently promoted to Professor!
Simon has transformed the Cancer Research portfolio at Sussex with his work at the Sussex BCR and the creation of @sussexcancer.org
🙌👊👏
A massive congratulations to Simon Mitchell @mitchell.science from @bsmsmedschool.bsky.social recently promoted to Professor!
Simon has transformed the Cancer Research portfolio at Sussex with his work at the Sussex BCR and the creation of @sussexcancer.org
🙌👊👏
Excited to have been promoted to Professor in Cancer Systems Biology at @bsmsmedschool.bsky.social, University of Sussex, @uniofbrighton.bsky.social
October 11, 2025 at 3:47 PM
🍾New promotion in the network! 🎉
A massive congratulations to Simon Mitchell @mitchell.science from @bsmsmedschool.bsky.social recently promoted to Professor!
Simon has transformed the Cancer Research portfolio at Sussex with his work at the Sussex BCR and the creation of @sussexcancer.org
🙌👊👏
A massive congratulations to Simon Mitchell @mitchell.science from @bsmsmedschool.bsky.social recently promoted to Professor!
Simon has transformed the Cancer Research portfolio at Sussex with his work at the Sussex BCR and the creation of @sussexcancer.org
🙌👊👏
Reposted by Sussex Blood Cancer Research
Excited to have been promoted to Professor in Cancer Systems Biology at @bsmsmedschool.bsky.social, University of Sussex, @uniofbrighton.bsky.social
October 9, 2025 at 8:20 PM
Excited to have been promoted to Professor in Cancer Systems Biology at @bsmsmedschool.bsky.social, University of Sussex, @uniofbrighton.bsky.social
Reposted by Sussex Blood Cancer Research
Many cancers begin as precancerous conditions. But what happens when these early cells coexist with a full-blown tumour?
Join us for an MRC funded PhD studentship exploring how primary cancers influence the evolution of precancerous cells.
www.findaphd.com/phds/project...
Join us for an MRC funded PhD studentship exploring how primary cancers influence the evolution of precancerous cells.
www.findaphd.com/phds/project...
(MRC DTP) Corrupting the roots: How leukaemia reshapes its ancestors at The University of Manchester on FindAPhD.com
PhD Project - (MRC DTP) Corrupting the roots: How leukaemia reshapes its ancestors at The University of Manchester, listed on FindAPhD.com
www.findaphd.com
October 10, 2025 at 9:16 AM
Many cancers begin as precancerous conditions. But what happens when these early cells coexist with a full-blown tumour?
Join us for an MRC funded PhD studentship exploring how primary cancers influence the evolution of precancerous cells.
www.findaphd.com/phds/project...
Join us for an MRC funded PhD studentship exploring how primary cancers influence the evolution of precancerous cells.
www.findaphd.com/phds/project...
💰New funding update💰
Congratulations @rhysmorganlab.bsky.social in @biochembiomeduos.bsky.social for obtaining funding from @bloodcanceruk.bsky.social to target abnormal cell signalling mechanisms in AML.
This is now 1 of 6 active Blood Cancer UK grants in our growing network at Sussex. 👊 🔬🧬🥼🩸
Congratulations @rhysmorganlab.bsky.social in @biochembiomeduos.bsky.social for obtaining funding from @bloodcanceruk.bsky.social to target abnormal cell signalling mechanisms in AML.
This is now 1 of 6 active Blood Cancer UK grants in our growing network at Sussex. 👊 🔬🧬🥼🩸
Very grateful to have been awarded our first @bloodcanceruk.bsky.social research grant over the summer for our work targeting aberrant Wnt/β-catenin signalling in acute myeloid leukaemia (AML).
Our new project headed by Dr Wagstaff begins Oct 1st developing new ways to target oncogenic β-catenin 👊
Our new project headed by Dr Wagstaff begins Oct 1st developing new ways to target oncogenic β-catenin 👊
October 7, 2025 at 6:53 AM
💰New funding update💰
Congratulations @rhysmorganlab.bsky.social in @biochembiomeduos.bsky.social for obtaining funding from @bloodcanceruk.bsky.social to target abnormal cell signalling mechanisms in AML.
This is now 1 of 6 active Blood Cancer UK grants in our growing network at Sussex. 👊 🔬🧬🥼🩸
Congratulations @rhysmorganlab.bsky.social in @biochembiomeduos.bsky.social for obtaining funding from @bloodcanceruk.bsky.social to target abnormal cell signalling mechanisms in AML.
This is now 1 of 6 active Blood Cancer UK grants in our growing network at Sussex. 👊 🔬🧬🥼🩸
Reposted by Sussex Blood Cancer Research
Very grateful to have been awarded our first @bloodcanceruk.bsky.social research grant over the summer for our work targeting aberrant Wnt/β-catenin signalling in acute myeloid leukaemia (AML).
Our new project headed by Dr Wagstaff begins Oct 1st developing new ways to target oncogenic β-catenin 👊
Our new project headed by Dr Wagstaff begins Oct 1st developing new ways to target oncogenic β-catenin 👊
September 30, 2025 at 3:06 PM
Very grateful to have been awarded our first @bloodcanceruk.bsky.social research grant over the summer for our work targeting aberrant Wnt/β-catenin signalling in acute myeloid leukaemia (AML).
Our new project headed by Dr Wagstaff begins Oct 1st developing new ways to target oncogenic β-catenin 👊
Our new project headed by Dr Wagstaff begins Oct 1st developing new ways to target oncogenic β-catenin 👊
Reposted by Sussex Blood Cancer Research
Delighted to wave the flag for @gdsc-sussex.bsky.social
@sussexcancer.org
@sussexbcr.bsky.social
sussexcancerfund.co.uk together with Rhys Morgan at the Science Cafe, MacMillan Horizon centre today. Thanks to Rebecca Herbertson and Stephen Robinson for organizing.
@rhysmorganlab.bsky.social
@sussexcancer.org
@sussexbcr.bsky.social
sussexcancerfund.co.uk together with Rhys Morgan at the Science Cafe, MacMillan Horizon centre today. Thanks to Rebecca Herbertson and Stephen Robinson for organizing.
@rhysmorganlab.bsky.social
September 29, 2025 at 8:26 PM
Delighted to wave the flag for @gdsc-sussex.bsky.social
@sussexcancer.org
@sussexbcr.bsky.social
sussexcancerfund.co.uk together with Rhys Morgan at the Science Cafe, MacMillan Horizon centre today. Thanks to Rebecca Herbertson and Stephen Robinson for organizing.
@rhysmorganlab.bsky.social
@sussexcancer.org
@sussexbcr.bsky.social
sussexcancerfund.co.uk together with Rhys Morgan at the Science Cafe, MacMillan Horizon centre today. Thanks to Rebecca Herbertson and Stephen Robinson for organizing.
@rhysmorganlab.bsky.social
Our Co-Directors Prof @chrispepper68.bsky.social and Dr @rhysmorganlab.bsky.social explain the mission and vision for the Sussex Blood Cancer Research network.
@sussexcancer.org @bsmsmedschool.bsky.social @biochembiomeduos.bsky.social
@sussexcancer.org @bsmsmedschool.bsky.social @biochembiomeduos.bsky.social
💡 How are #BSMS researchers working to change the future of blood cancer?
Prof Chris Pepper and Dr Rhys Morgan share their journey, their goals and why this research matters.
▶Watch here: www.youtube.com/watch?v=0EwD...
@sussexbcr.bsky.social #MedicalResearch
Prof Chris Pepper and Dr Rhys Morgan share their journey, their goals and why this research matters.
▶Watch here: www.youtube.com/watch?v=0EwD...
@sussexbcr.bsky.social #MedicalResearch
Prof Chris Pepper and Dr Rhys Morgan - Sussex Blood Cancer Research
YouTube video by Brighton and Sussex Medical School
www.youtube.com
September 23, 2025 at 4:17 PM
Our Co-Directors Prof @chrispepper68.bsky.social and Dr @rhysmorganlab.bsky.social explain the mission and vision for the Sussex Blood Cancer Research network.
@sussexcancer.org @bsmsmedschool.bsky.social @biochembiomeduos.bsky.social
@sussexcancer.org @bsmsmedschool.bsky.social @biochembiomeduos.bsky.social
Reposted by Sussex Blood Cancer Research
💡 How are #BSMS researchers working to change the future of blood cancer?
Prof Chris Pepper and Dr Rhys Morgan share their journey, their goals and why this research matters.
▶Watch here: www.youtube.com/watch?v=0EwD...
@sussexbcr.bsky.social #MedicalResearch
Prof Chris Pepper and Dr Rhys Morgan share their journey, their goals and why this research matters.
▶Watch here: www.youtube.com/watch?v=0EwD...
@sussexbcr.bsky.social #MedicalResearch
Prof Chris Pepper and Dr Rhys Morgan - Sussex Blood Cancer Research
YouTube video by Brighton and Sussex Medical School
www.youtube.com
September 23, 2025 at 7:33 AM
💡 How are #BSMS researchers working to change the future of blood cancer?
Prof Chris Pepper and Dr Rhys Morgan share their journey, their goals and why this research matters.
▶Watch here: www.youtube.com/watch?v=0EwD...
@sussexbcr.bsky.social #MedicalResearch
Prof Chris Pepper and Dr Rhys Morgan share their journey, their goals and why this research matters.
▶Watch here: www.youtube.com/watch?v=0EwD...
@sussexbcr.bsky.social #MedicalResearch
🗞️ New network publication!🗞️
Final year PhD student Aimilia Vareli in @bsmsmedschool.bsky.social of @mitchell.science lab publishes her doctoral studies in @springernature.com
#CellDeathDisease showing inhibition of NFkB signalling increases BH3 mimetic sensitivity in the lymphoma microenvironment.
Final year PhD student Aimilia Vareli in @bsmsmedschool.bsky.social of @mitchell.science lab publishes her doctoral studies in @springernature.com
#CellDeathDisease showing inhibition of NFkB signalling increases BH3 mimetic sensitivity in the lymphoma microenvironment.
New paper led by Aimilia Vareli out now.
nature.com/articles/s41...
The lymphoma microenvironment stops BH3-mimetics working.
In vitro/vivo/silico, we find inhibition of NFκB makes BH3-mimetics great again.🧵
@sussexbcr.bsky.social @bsmsmedschool.bsky.social @leukaemiauk.bsky.social @sussexcancer.org
nature.com/articles/s41...
The lymphoma microenvironment stops BH3-mimetics working.
In vitro/vivo/silico, we find inhibition of NFκB makes BH3-mimetics great again.🧵
@sussexbcr.bsky.social @bsmsmedschool.bsky.social @leukaemiauk.bsky.social @sussexcancer.org
Systems biology-enabled targeting of NF-κΒ and BCL2 overcomes microenvironment-mediated BH3-mimetic resistance in DLBCL - Cell Death & Disease
Cell Death & Disease - Systems biology-enabled targeting of NF-κΒ and BCL2 overcomes microenvironment-mediated BH3-mimetic resistance in DLBCL
nature.com
September 9, 2025 at 10:11 AM
🗞️ New network publication!🗞️
Final year PhD student Aimilia Vareli in @bsmsmedschool.bsky.social of @mitchell.science lab publishes her doctoral studies in @springernature.com
#CellDeathDisease showing inhibition of NFkB signalling increases BH3 mimetic sensitivity in the lymphoma microenvironment.
Final year PhD student Aimilia Vareli in @bsmsmedschool.bsky.social of @mitchell.science lab publishes her doctoral studies in @springernature.com
#CellDeathDisease showing inhibition of NFkB signalling increases BH3 mimetic sensitivity in the lymphoma microenvironment.
Reposted by Sussex Blood Cancer Research
New paper led by Aimilia Vareli out now.
nature.com/articles/s41...
The lymphoma microenvironment stops BH3-mimetics working.
In vitro/vivo/silico, we find inhibition of NFκB makes BH3-mimetics great again.🧵
@sussexbcr.bsky.social @bsmsmedschool.bsky.social @leukaemiauk.bsky.social @sussexcancer.org
nature.com/articles/s41...
The lymphoma microenvironment stops BH3-mimetics working.
In vitro/vivo/silico, we find inhibition of NFκB makes BH3-mimetics great again.🧵
@sussexbcr.bsky.social @bsmsmedschool.bsky.social @leukaemiauk.bsky.social @sussexcancer.org
Systems biology-enabled targeting of NF-κΒ and BCL2 overcomes microenvironment-mediated BH3-mimetic resistance in DLBCL - Cell Death & Disease
Cell Death & Disease - Systems biology-enabled targeting of NF-κΒ and BCL2 overcomes microenvironment-mediated BH3-mimetic resistance in DLBCL
nature.com
August 18, 2025 at 11:05 AM
New paper led by Aimilia Vareli out now.
nature.com/articles/s41...
The lymphoma microenvironment stops BH3-mimetics working.
In vitro/vivo/silico, we find inhibition of NFκB makes BH3-mimetics great again.🧵
@sussexbcr.bsky.social @bsmsmedschool.bsky.social @leukaemiauk.bsky.social @sussexcancer.org
nature.com/articles/s41...
The lymphoma microenvironment stops BH3-mimetics working.
In vitro/vivo/silico, we find inhibition of NFκB makes BH3-mimetics great again.🧵
@sussexbcr.bsky.social @bsmsmedschool.bsky.social @leukaemiauk.bsky.social @sussexcancer.org
Join Dr Jasmeen Oberoi's research group on a @bloodcanceruk.bsky.social funded project as a Research Technician in Protein Biochemistry for 6mo, investigating structure and function of fusion kinase complexes in leukaemia.
Great opportunity for a candidate looking to build research experience!
Great opportunity for a candidate looking to build research experience!
🧬🧪 A research technician position - Protein Biochemistry (6 months) is available in my lab @gdsc-sussex.bsky.social investigating structure and function of fusion kinase complexes in Leukaemia.
📅 Deadline: 29th September 2025.
🙏 Please share with anyone who might be interested.
📅 Deadline: 29th September 2025.
🙏 Please share with anyone who might be interested.
Research Technician – Protein Biochemistry at University of Sussex
Explore an exciting academic career as a Research Technician – Protein Biochemistry. Don't miss out on other academic jobs. Click to apply and explore more opportunities.
www.jobs.ac.uk
September 9, 2025 at 10:08 AM
Join Dr Jasmeen Oberoi's research group on a @bloodcanceruk.bsky.social funded project as a Research Technician in Protein Biochemistry for 6mo, investigating structure and function of fusion kinase complexes in leukaemia.
Great opportunity for a candidate looking to build research experience!
Great opportunity for a candidate looking to build research experience!
Reposted by Sussex Blood Cancer Research
🧬🧪 A research technician position - Protein Biochemistry (6 months) is available in my lab @gdsc-sussex.bsky.social investigating structure and function of fusion kinase complexes in Leukaemia.
📅 Deadline: 29th September 2025.
🙏 Please share with anyone who might be interested.
📅 Deadline: 29th September 2025.
🙏 Please share with anyone who might be interested.
Research Technician – Protein Biochemistry at University of Sussex
Explore an exciting academic career as a Research Technician – Protein Biochemistry. Don't miss out on other academic jobs. Click to apply and explore more opportunities.
www.jobs.ac.uk
September 9, 2025 at 8:35 AM
🧬🧪 A research technician position - Protein Biochemistry (6 months) is available in my lab @gdsc-sussex.bsky.social investigating structure and function of fusion kinase complexes in Leukaemia.
📅 Deadline: 29th September 2025.
🙏 Please share with anyone who might be interested.
📅 Deadline: 29th September 2025.
🙏 Please share with anyone who might be interested.
Reposted by Sussex Blood Cancer Research
Research is never a solo effort.
It takes teamwork. It takes belief. It takes collaboration across disciplines, institutions, and communities.
We know what it takes to beat blood cancer.
#BloodCancerAwarenessMonth
@bloodcanceruk.bsky.social @sussexbcr.bsky.social @sussexcancer.org 🩸
It takes teamwork. It takes belief. It takes collaboration across disciplines, institutions, and communities.
We know what it takes to beat blood cancer.
#BloodCancerAwarenessMonth
@bloodcanceruk.bsky.social @sussexbcr.bsky.social @sussexcancer.org 🩸
September 4, 2025 at 2:18 PM
Research is never a solo effort.
It takes teamwork. It takes belief. It takes collaboration across disciplines, institutions, and communities.
We know what it takes to beat blood cancer.
#BloodCancerAwarenessMonth
@bloodcanceruk.bsky.social @sussexbcr.bsky.social @sussexcancer.org 🩸
It takes teamwork. It takes belief. It takes collaboration across disciplines, institutions, and communities.
We know what it takes to beat blood cancer.
#BloodCancerAwarenessMonth
@bloodcanceruk.bsky.social @sussexbcr.bsky.social @sussexcancer.org 🩸
🗞️ New network publication! 📰
Final year PhD student Aimilia Vareli in @bsmsmedschool.bsky.social in the @mitchell.science lab publishes her doctoral studies in @springernature.com #CellDeathDisease showing inhibition of NFkB signalling increases sensitivity to BH3 mimetics for lymphoma treatment.
Final year PhD student Aimilia Vareli in @bsmsmedschool.bsky.social in the @mitchell.science lab publishes her doctoral studies in @springernature.com #CellDeathDisease showing inhibition of NFkB signalling increases sensitivity to BH3 mimetics for lymphoma treatment.
New paper led by Aimilia Vareli out now.
nature.com/articles/s41...
The lymphoma microenvironment stops BH3-mimetics working.
In vitro/vivo/silico, we find inhibition of NFκB makes BH3-mimetics great again.🧵
@sussexbcr.bsky.social @bsmsmedschool.bsky.social @leukaemiauk.bsky.social @sussexcancer.org
nature.com/articles/s41...
The lymphoma microenvironment stops BH3-mimetics working.
In vitro/vivo/silico, we find inhibition of NFκB makes BH3-mimetics great again.🧵
@sussexbcr.bsky.social @bsmsmedschool.bsky.social @leukaemiauk.bsky.social @sussexcancer.org
Systems biology-enabled targeting of NF-κΒ and BCL2 overcomes microenvironment-mediated BH3-mimetic resistance in DLBCL - Cell Death & Disease
Cell Death & Disease - Systems biology-enabled targeting of NF-κΒ and BCL2 overcomes microenvironment-mediated BH3-mimetic resistance in DLBCL
nature.com
August 28, 2025 at 5:43 PM
🗞️ New network publication! 📰
Final year PhD student Aimilia Vareli in @bsmsmedschool.bsky.social in the @mitchell.science lab publishes her doctoral studies in @springernature.com #CellDeathDisease showing inhibition of NFkB signalling increases sensitivity to BH3 mimetics for lymphoma treatment.
Final year PhD student Aimilia Vareli in @bsmsmedschool.bsky.social in the @mitchell.science lab publishes her doctoral studies in @springernature.com #CellDeathDisease showing inhibition of NFkB signalling increases sensitivity to BH3 mimetics for lymphoma treatment.
Reposted by Sussex Blood Cancer Research
Great post-doctoral opportunity in the laboratory of Dr Jasmeen Oberoi — who has just joined us as a team leader in the GDSC.
📢 New Postdoc opportunity
🧬🧪🩸 Excited to share an MRC funded Research Fellow position is available in my lab @gdsc-sussex.bsky.social to investigate novel approaches to disrupt the function of fusion kinases and their regulation by the HSP90 molecular chaperone system in leukaemia.
🧬🧪🩸 Excited to share an MRC funded Research Fellow position is available in my lab @gdsc-sussex.bsky.social to investigate novel approaches to disrupt the function of fusion kinases and their regulation by the HSP90 molecular chaperone system in leukaemia.
Research Fellow in Cancer Research at University of Sussex
An academic position as a Research Fellow in Cancer Research is being advertised on jobs.ac.uk. Click now to find more details and explore additional academic job opportunities.
www.jobs.ac.uk
July 18, 2025 at 2:01 PM
Great post-doctoral opportunity in the laboratory of Dr Jasmeen Oberoi — who has just joined us as a team leader in the GDSC.
Reposted by Sussex Blood Cancer Research
📢 New Postdoc opportunity
🧬🧪🩸 Excited to share an MRC funded Research Fellow position is available in my lab @gdsc-sussex.bsky.social to investigate novel approaches to disrupt the function of fusion kinases and their regulation by the HSP90 molecular chaperone system in leukaemia.
🧬🧪🩸 Excited to share an MRC funded Research Fellow position is available in my lab @gdsc-sussex.bsky.social to investigate novel approaches to disrupt the function of fusion kinases and their regulation by the HSP90 molecular chaperone system in leukaemia.
Research Fellow in Cancer Research at University of Sussex
An academic position as a Research Fellow in Cancer Research is being advertised on jobs.ac.uk. Click now to find more details and explore additional academic job opportunities.
www.jobs.ac.uk
July 17, 2025 at 5:11 PM
📢 New Postdoc opportunity
🧬🧪🩸 Excited to share an MRC funded Research Fellow position is available in my lab @gdsc-sussex.bsky.social to investigate novel approaches to disrupt the function of fusion kinases and their regulation by the HSP90 molecular chaperone system in leukaemia.
🧬🧪🩸 Excited to share an MRC funded Research Fellow position is available in my lab @gdsc-sussex.bsky.social to investigate novel approaches to disrupt the function of fusion kinases and their regulation by the HSP90 molecular chaperone system in leukaemia.
Completed your PhD? Interested in leukaemia research? Want to join a new/exciting PI as they establish their group at @gdsc-sussex.bsky.social
Then this post doc with new MRC CDA Fellow & @bloodcanceruk.bsky.social funded Dr @jasmeenoberoi.bsky.social is 4 you 👇
jobs.sussex.ac.uk/job/fe31a03c...
Then this post doc with new MRC CDA Fellow & @bloodcanceruk.bsky.social funded Dr @jasmeenoberoi.bsky.social is 4 you 👇
jobs.sussex.ac.uk/job/fe31a03c...
Research Fellow in Cancer Research Ref: 41067 (Fixed Term) - Job page - University of Sussex Job Search
jobs.sussex.ac.uk
July 17, 2025 at 2:23 PM
Completed your PhD? Interested in leukaemia research? Want to join a new/exciting PI as they establish their group at @gdsc-sussex.bsky.social
Then this post doc with new MRC CDA Fellow & @bloodcanceruk.bsky.social funded Dr @jasmeenoberoi.bsky.social is 4 you 👇
jobs.sussex.ac.uk/job/fe31a03c...
Then this post doc with new MRC CDA Fellow & @bloodcanceruk.bsky.social funded Dr @jasmeenoberoi.bsky.social is 4 you 👇
jobs.sussex.ac.uk/job/fe31a03c...
🗞️ New publication from the network 🗞️
Dr @ejayawant.bsky.social now working at the Pepper group in @bsmsmedschool.bsky.social review the state of play in computational modelling of B-cell lymphomas, led by @mitchell.science and now out at @biochemsoc.bsky.social Transactions.
Dr @ejayawant.bsky.social now working at the Pepper group in @bsmsmedschool.bsky.social review the state of play in computational modelling of B-cell lymphomas, led by @mitchell.science and now out at @biochemsoc.bsky.social Transactions.
New paper led by @ejayawant.bsky.social 🎉
We review:
- how computational biology is helping us understand lymphoma,
- how machine learning and cell simulations make sense of vast amounts of data,
- how models can personalise treatments to each person with lymphoma.
portlandpress.com/biochemsoctr...
We review:
- how computational biology is helping us understand lymphoma,
- how machine learning and cell simulations make sense of vast amounts of data,
- how models can personalise treatments to each person with lymphoma.
portlandpress.com/biochemsoctr...
July 7, 2025 at 2:53 PM
🗞️ New publication from the network 🗞️
Dr @ejayawant.bsky.social now working at the Pepper group in @bsmsmedschool.bsky.social review the state of play in computational modelling of B-cell lymphomas, led by @mitchell.science and now out at @biochemsoc.bsky.social Transactions.
Dr @ejayawant.bsky.social now working at the Pepper group in @bsmsmedschool.bsky.social review the state of play in computational modelling of B-cell lymphomas, led by @mitchell.science and now out at @biochemsoc.bsky.social Transactions.
Reposted by Sussex Blood Cancer Research
New paper led by @ejayawant.bsky.social 🎉
We review:
- how computational biology is helping us understand lymphoma,
- how machine learning and cell simulations make sense of vast amounts of data,
- how models can personalise treatments to each person with lymphoma.
portlandpress.com/biochemsoctr...
We review:
- how computational biology is helping us understand lymphoma,
- how machine learning and cell simulations make sense of vast amounts of data,
- how models can personalise treatments to each person with lymphoma.
portlandpress.com/biochemsoctr...
July 4, 2025 at 4:02 PM
New paper led by @ejayawant.bsky.social 🎉
We review:
- how computational biology is helping us understand lymphoma,
- how machine learning and cell simulations make sense of vast amounts of data,
- how models can personalise treatments to each person with lymphoma.
portlandpress.com/biochemsoctr...
We review:
- how computational biology is helping us understand lymphoma,
- how machine learning and cell simulations make sense of vast amounts of data,
- how models can personalise treatments to each person with lymphoma.
portlandpress.com/biochemsoctr...
Reposted by Sussex Blood Cancer Research
Artist’s blood cancer treatment inspires powerful new exhibition at University of Brighton, @bsmsmedschool.bsky.social
www.brighton.ac.uk/news/2025/ar...
www.brighton.ac.uk/news/2025/ar...
Artist’s blood cancer treatment inspires powerful new exhibition at University of Brighton
A University of Brighton graduate has turned his own cancer journey into a striking art installation exploring illness and the duality of medical treatment.
www.brighton.ac.uk
June 10, 2025 at 9:39 PM
Artist’s blood cancer treatment inspires powerful new exhibition at University of Brighton, @bsmsmedschool.bsky.social
www.brighton.ac.uk/news/2025/ar...
www.brighton.ac.uk/news/2025/ar...